ORAL QUESTION H-0844/08 for Question Time at the part-session in November 2008 pursuant to Rule 109 of the Rules of Procedure by Alojz Peterle to the Commission Subject: Cancer research On 10 April this year the European Parliament adopted a Resolution ( P6_TA(2008)0121 ) on combating cancer in the enlarged European Union. Realising the fragmented nature of cancer research across Europe, the EP called for better collaboration and less duplication between different research efforts to bring the fruits of research faster to the cancer patient. What is the Commission doing to encourage and support more transnational cancer research under FP7? How is the Commission planning to support research into rare and difficult-to-treat cancers, such as paediatric cancers, where market incentives often fail to stimulate commercial investment in research?